Unwrap.Fund
See how KURE fits your portfolio →
ETF · holdings as filed 2026-03-31

What's inside KURE?

KraneShares MSCI All China Health Care Index ETF
Holdings
48
positions in the fund
Top 10
54%
of fund assets
Expense ratio
0.65%
net, per year
Fund size
$80M
total net assets

Top 20 holdings

RankLogoTicker / NameWeight
1
I
IVBXFINNOVENT BIOLOGICS INC
8.56%
2
B
BEIGFBEONE MEDICINES LTD-H
8.06%
3
W
WXIBFWUXI BIOLOGICS CAYMAN INC
6.54%
4
A
AKESFAKESO INC
5.66%
5
6
603259WUXI APPTEC CO LTD-A
5.60%
6
6
600276JIANGSU HENGRUI PHARMACEUT-A
4.52%
7
3
300760SHENZHEN MINDRAY BIO-MEDIC-A
4.22%
8
S
SBMFFSINO BIOPHARMACEUTICAL
4.12%
9
C
CHJTFCSPC PHARMACEUTICAL GROUP LT
3.56%
10
H
HNSPFHANSOH PHARMACEUTICAL GROUP
3.54%
11
W
WUXIFWUXI APPTEC CO LTD-H
3.08%
12
T
TRSBF3SBIO INC
2.84%
13
0
000538YUNNAN BAIYAO GROUP CO LTD-A
2.18%
14
6
688271SHANGHAI UNITED IMAGING HE-A
2.13%
15
6
600436ZHANGZHOU PIENTZEHUANG PHA-A
2.05%
16
3
300015AIER EYE HOSPITAL GROUP CO-A
1.99%
17
S
SHTDFSINOPHARM GROUP CO-H
1.82%
18
0
002294SHENZHEN SALUBRIS PHARM-A
1.58%
19
S
SKBHFSICHUAN KELUN-BIOTECH BIOP-H
1.54%
20
A
AGPXXINVESCO GVT & AGNCY-INST
1.53%
Sectors
Top holdings — Unclassified
Your 10 largest positions in this sector
1
I
IVBXFINNOVENT BIOLOGICS INC
8.56%
2
W
WXIBFWUXI BIOLOGICS CAYMAN INC
6.54%
3
A
AKESFAKESO INC
5.66%
4
6
603259WUXI APPTEC CO LTD-A
5.60%
5
6
600276JIANGSU HENGRUI PHARMACEUT-A
4.52%
6
3
300760SHENZHEN MINDRAY BIO-MEDIC-A
4.22%
7
S
SBMFFSINO BIOPHARMACEUTICAL
4.12%
8
C
CHJTFCSPC PHARMACEUTICAL GROUP LT
3.56%
9
H
HNSPFHANSOH PHARMACEUTICAL GROUP
3.54%
10
W
WUXIFWUXI APPTEC CO LTD-H
3.08%
Geography
Top holdings — China
Your 10 largest positions in this country
1
6
603259WUXI APPTEC CO LTD-A
5.60%
2
6
600276JIANGSU HENGRUI PHARMACEUT-A
4.52%
3
3
300760SHENZHEN MINDRAY BIO-MEDIC-A
4.22%
4
W
WUXIFWUXI APPTEC CO LTD-H
3.08%
5
0
000538YUNNAN BAIYAO GROUP CO LTD-A
2.18%
6
6
688271SHANGHAI UNITED IMAGING HE-A
2.13%
7
6
600436ZHANGZHOU PIENTZEHUANG PHA-A
2.05%
8
3
300015AIER EYE HOSPITAL GROUP CO-A
1.99%
9
S
SHTDFSINOPHARM GROUP CO-H
1.82%
10
0
002294SHENZHEN SALUBRIS PHARM-A
1.58%
Geography reflects each issuer's registered business address per SEC EDGAR filings where available, falling back to the exchange or listing where no SEC filing exists — not necessarily where a company's stock is primarily listed (e.g. TSMC is classified as Taiwan even though its ADR trades on the NYSE).
Hold KURE alongside other funds? See your combined true holdings, overlap, and blended fees — free, no signup.
Unwrap your portfolio →
Funds similar to KURE
MCHIiShares MSCI China ETF
5% overlap
Compare →
GXCState Street(R) SPDR(R) S&P(R) China ETF
4% overlap
Compare →
BKFiShares MSCI BIC ETF
3% overlap
Compare →
EMXFiShares ESG Advanced MSCI EM ETF
2% overlap
Compare →
EEMAiShares MSCI Emerging Markets Asia ETF
1% overlap
Compare →
EEMXState Street(R) SPDR(R) MSCI Emerging Markets Fossil Fuel Reserves Free ETF
1% overlap
Compare →
Data source: official SEC Form N-PORT filings (as of 2026-03-31); expense ratio from SEC prospectus (risk/return) filings. Fund holdings are disclosed quarterly and may reflect a 60-day reporting delay.
Informational and educational only — not investment advice.